µ­±â¿­ °Ë»ç ½ÃÀå º¸°í¼­ : °Ë»ç À¯Çü, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)
Dengue Testing Market Report by Test Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Region 2025-2033
»óǰÄÚµå : 1722774
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 144 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,177,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,569,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,962,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

µ­±â¿­ °Ë»ç ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 6¾ï 1,080¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ÀÌ ½ÃÀåÀÌ 2033³â±îÁö 9¾ï 1,170¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â 4.32%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÁÖ·Î Àü ¼¼°è µ­±â¿­ À¯Çà Áõ°¡, Áø´Ü ±â¼úÀÇ ¹ßÀü, °øÁß º¸°Ç¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Àü ¼¼°è À¯Çà Áö¿ª¿¡¼­ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÀÚ±Ý Áö¿øÀ¸·Î ÀÎÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

µ­±â¿­Àº °¨¿°µÈ µ­±â¿­ ¸ð±â¿¡ ¹°·Á °¨¿°µÇ´Â ¹ÙÀÌ·¯½º¼º °¨¿°º´ÀÔ´Ï´Ù. °üÀý°ú ±ÙÀ°Åë, °í¿­, º¹Åë, ±¸Åä, ±¸Åä, È£Èí°ï¶õ, ÇǺÎÀÇ ¼öÆ÷, µÎÅë, ´«ÀÇ ÅëÁõ, ÇǷΰ¨, ¹ßÁø, ÄÚ¿Í ÀÕ¸öÀÇ °¡º­¿î ÃâÇ÷ µîÀ» À¯¹ßÇÕ´Ï´Ù. µ­±â¿­Àº È¿¼Ò °áÇÕ ¸é¿ª ÈíÂø ÃøÁ¤¹ý(ELISA), RT-PCR, µ­±â¿­ IgG/IgM ½Å¼Ó °Ë»ç µîÀÇ µ­±â¿­ °Ë»ç·Î Áø´ÜÇÒ ¼ö ÀÖ½À´Ï´Ù. µ­±â¿­ °Ë»ç´Â ÀÇ·á Àü¹®°¡°¡ Ç÷¾× »ùÇÃÀ» ÀÌ¿ëÇÏ¿© µ­±â¿­ ¹ÙÀÌ·¯½ºÀÇ ´Ù¾çÇÑ Ç÷ûÇüÀ» È®ÀÎÇϱâ À§ÇØ ½ÃÇàÇÕ´Ï´Ù.

µ­±â¿­ °Ë»ç ½ÃÀå µ¿Çâ :

Áö±¸ ¿Â³­È­¿Í ¸ð±â ¹ø½ÄÁö Áõ°¡·Î ÀÎÇÑ µ­±â¿­ ȯÀÚ Áõ°¡´Â ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, µ­±â¿­ÀÇ Á¤È®Çϰí È¿À²ÀûÀÎ Áø´ÜÀº ÀÓ»ó Ä¡·á¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. µ­±â¿­ÀÇ Á¤È®Çϰí È¿À²ÀûÀÎ Áø´ÜÀº ÀÓ»ó ÀÇ·á¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, º´ÀÎ ±Ô¸í, ÀÓ»ó½ÃÇè, ¹ßº´ ´ëÃ¥, Çмú ¿¬±¸, ¹é½Å °³¹ß, °¨½Ã Ȱµ¿, ÁßÁõ »ç·ÊÀÇ Á¶±â ¹ß°ß, »ç·Ê È®ÀÎ, ´Ù¸¥ Àü¿°º´°úÀÇ °¨º° Áø´Ü µî¿¡ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡Àº Àü ¼¼°è µ­±â¿­ °Ë»ç ¼ö¿ä¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ¿Í ´õºÒ¾î, Àü ¼¼°è Àα¸ ¹ÐÁý Áö¿ªÀº ¿­¾ÇÇÑ »ýȰ ȯ°æÀ¸·Î ÀÎÇØ Áúº´¿¡ °É¸®±â ½±½À´Ï´Ù. ÀÌ´Â ´ëÁßÀÇ ÀÎ½Ä ºÎÁ·À¸·Î ÀÎÇÑ ¿­¾ÇÇÑ À§»ý ȯ°æ ¹× Æó±â¹° °ü¸® ±â¼ú°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á Àü¹®°¡µéÀº »ç¶÷µé¿¡°Ô Àڱ⠹æ¾î¿Í »ìÃæÁ¦ ¿­ ºÐ¹«·Î µ­±â¿­À» ¿¹¹æÇÒ °ÍÀ» Ã˱¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¿©·¯ ±¹°¡ÀÇ Á¤ºÎ°¡ Á¶Á÷ÇÑ ÀÎ½Ä Á¦°í Ä·ÆäÀΰú ÇÔ²² ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ´Ù¸¥ ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â ±Þ¼ÓÇÑ µµ½ÃÈ­¿Í ÇコÄÉ¾î »ê¾÷ÀÇ ±â¼ú ¹ßÀüÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷µéÀº °íÈ¿À²ÀûÀÌ°í ºñ¿ë È¿À²ÀûÀÎ µ­±â¿­ °Ë»ç ŰƮ¸¦ °³¹ßÇϱâ À§ÇØ ¿¬±¸ °³¹ß(R&D) Ȱµ¿¿¡ ±¤¹üÀ§ÇÏ°Ô ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ µ­±â¿­ °Ë»ç ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : °Ë»ç À¯Çüº°

Á¦7Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦8Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå SWOT ºÐ¼®

Á¦10Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦11Àå PorterÀÇ Five Forces ºÐ¼®

Á¦12Àå °¡°Ý ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global dengue testing market size reached USD 610.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 911.7 Million by 2033, exhibiting a growth rate (CAGR) of 4.32% during 2025-2033. The market is primarily driven by the increasing dengue fever prevalence worldwide, advancements in diagnostic technologies, rising public health awareness, and government initiatives and funding in endemic regions across the globe.

Dengue, also known as breakbone fever, is a viral infection that spreads through the bite of an infected Aedes aegypti mosquito. It causes ache in the joints and muscles, high fever, abdominal pain, vomiting, difficulty in breathing, clammy and cold skin, headache, pain behind the eyes, fatigue, rashes, and mild bleeding in the nose and gums. It is diagnosed via dengue testing, which includes enzyme-linked immunosorbent assay (ELISA), RT-PCR, and dengue IgG/IgM rapid tests. Dengue testing is performed by medical professionals using a blood sample to identify the different serotypes of the dengue virus.

Dengue Testing Market Trends:

The growing cases of dengue on account of the rising global warming and breeding sites of mosquitos across the globe represents one of the major factors driving the market. Moreover, accurate and efficient diagnosis of dengue plays a pivotal role in clinical care. It assists in pathogenesis, clinical trials, outbreak control, academic research, vaccine development, surveillance activities, early detection of severe cases, and case confirmation and differential diagnosis with other infectious diseases. These benefits are positively influencing the demand for dengue testing around the world. Besides this, densely populated areas worldwide are more disease-prone due to low living conditions. This, along with poor sanitation and waste management techniques due to lack of public awareness, is stimulating the growth of the market. In addition, healthcare professionals are encouraging people to prevent dengue by self-protection and thermal fogging of insecticides. This, coupled with awareness campaigns organized by the government of several countries, is propelling the growth of the market. Other growth-inducing factors are rapid urbanization and technological advancements in the healthcare industry. Furthermore, key market players are extensively investing in research and development (R&D) activities to develop highly efficient and cost-effective dengue test kits.

Key Market Segmentation:

Breakup by Test Type:

Breakup by End User:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Abnova Corporation, CerTest Biotec S.L., DiaSorin S.p.A., F. Hoffmann-La Roche AG, InBios International Inc., NovaTec Immundiagnostica GmbH, OriGene Technologies Inc., PerkinElmer Inc., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Dengue Testing Market

6 Market Breakup by Test Type

7 Market Breakup by End User

8 Market Breakup by Region

9 SWOT Analysis

10 Value Chain Analysis

11 Porters Five Forces Analysis

12 Price Analysis

13 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â